• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Trends on Epidemiology-Perspectives from a National Reference Laboratory Surveillance Program.流行病学趋势——来自国家参考实验室监测项目的视角
J Fungi (Basel). 2021 Jan 6;7(1):28. doi: 10.3390/jof7010028.
2
Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.从葡萄牙环境空气中采集的曲霉属物种-对依曲康唑耐药的烟曲霉狭义种的分子鉴定、抗真菌药敏性和 cyp51A 基因测序。
J Appl Microbiol. 2019 Apr;126(4):1140-1148. doi: 10.1111/jam.14217. Epub 2019 Feb 27.
3
Azole-Resistant Harboring the TR/L98H Mutation: First Report in Portugal in Environmental Samples.携带TR/L98H突变的唑类抗性:葡萄牙环境样本中的首例报告。
Microorganisms. 2020 Dec 28;9(1):57. doi: 10.3390/microorganisms9010057.
4
Prospective multicentre study on azole resistance in Aspergillus isolates from surveillance cultures in haematological patients in Italy.意大利血液病患者监测培养曲霉菌株中唑类耐药性的前瞻性多中心研究。
J Glob Antimicrob Resist. 2020 Sep;22:231-237. doi: 10.1016/j.jgar.2020.01.016. Epub 2020 Feb 13.
5
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato.梯度扩散带法检测烟曲霉及其近缘种的唑类药物耐药性。
Mycoses. 2023 Mar;66(3):196-201. doi: 10.1111/myc.13541. Epub 2022 Nov 2.
6
[Phenotypic and Genotypic Evaluation of Azole Resistance in Aspergillus fumigatus Isolates from Clinical and Environmental Specimens].[来自临床和环境样本的烟曲霉分离株中唑类耐药性的表型和基因型评估]
Mikrobiyol Bul. 2020 Apr;54(2):291-305. doi: 10.5578/mb.69024.
7
Species and Antifungals Susceptibility in Clinical Setting in the North of Portugal: Cryptic Species and Emerging Azoles Resistance in .葡萄牙北部临床环境中的菌种及抗真菌药敏情况:隐匿菌种与新型唑类耐药性研究
Front Microbiol. 2018 Jul 23;9:1656. doi: 10.3389/fmicb.2018.01656. eCollection 2018.
8
Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.在澳大利亚,对烟曲霉临床和环境分离株中的唑类耐药性进行监测,以及对唑类耐药分离株进行 Cyp51A 同源建模。
J Antimicrob Chemother. 2018 Sep 1;73(9):2347-2351. doi: 10.1093/jac/dky187.
9
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.人类致病酵母和丝状真菌的耐药性:流行情况、潜在分子机制以及与人类和环境中抗真菌药物使用的关联
Dan Med J. 2016 Oct;63(10).
10
Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes.丹麦的耐唑类烟曲霉:基于实验室的耐药机制和基因型研究。
Clin Microbiol Infect. 2016 Jun;22(6):570.e1-9. doi: 10.1016/j.cmi.2016.04.001. Epub 2016 Apr 16.

引用本文的文献

1
Addressing Critical Fungal Pathogens Under a One Health Perspective: Key Insights from the Portuguese Association of Medical Mycology.从“同一健康”视角应对关键真菌病原体:葡萄牙医学真菌学协会的重要见解
Mycopathologia. 2025 Aug 16;190(5):73. doi: 10.1007/s11046-025-00981-3.
2
Critical insights on fungal contamination in schools: a comprehensive review of assessment methods.关于学校真菌污染的关键见解:评估方法的全面综述
Front Public Health. 2025 Jun 23;13:1557506. doi: 10.3389/fpubh.2025.1557506. eCollection 2025.
3
Comprehensive Review of Environmental Surveillance for Azole-Resistant : A Practical Roadmap for Hospital Clinicians and Infection Control Teams.唑类耐药环境监测综合综述:医院临床医生和感染控制团队实用路线图
J Fungi (Basel). 2025 Jan 25;11(2):96. doi: 10.3390/jof11020096.
4
Azole Antifungal Consumption in Community Pharmacy Sales in Mainland Portugal: Trend Analysis from 2014 to 2023.葡萄牙大陆社区药房销售中唑类抗真菌药物的消费情况:2014年至2023年的趋势分析
Antibiotics (Basel). 2025 Jan 4;14(1):33. doi: 10.3390/antibiotics14010033.
5
Global research trends and hotspots on human intestinal fungi and health: a bibliometric visualization study.全球人类肠道真菌与健康研究趋势和热点:文献计量可视化研究。
Front Cell Infect Microbiol. 2024 Oct 17;14:1460570. doi: 10.3389/fcimb.2024.1460570. eCollection 2024.
6
Rethinking Aspergillosis in the Era of Microbiota and Mycobiota.重新思考微生物群和真菌群时代的曲霉病。
Mycopathologia. 2024 Jun 12;189(4):49. doi: 10.1007/s11046-024-00853-2.
7
Uncovering a Novel 51A Mutation and Antifungal Resistance in through Culture Collection Screening.通过菌种保藏筛选发现一种新的51A突变及抗真菌耐药性。
J Fungi (Basel). 2024 Feb 1;10(2):122. doi: 10.3390/jof10020122.
8
Epidemiology and Azole Resistance of Clinical Isolates of from a Large Tertiary Hospital in Ningxia, China.中国宁夏某大型三级医院临床分离株的流行病学及唑类耐药性
Infect Drug Resist. 2024 Feb 2;17:427-439. doi: 10.2147/IDR.S440363. eCollection 2024.
9
The Use of Galactomannan Antigen Assays for the Diagnosis of Invasive Pulmonary Aspergillosis in the Hematological Patient: A Systematic Review and Meta-Analysis.半乳甘露聚糖抗原检测在血液病患者侵袭性肺曲霉病诊断中的应用:一项系统评价和荟萃分析
J Fungi (Basel). 2023 Jun 15;9(6):674. doi: 10.3390/jof9060674.
10
Synergy Between Filtrates And Voriconazole Against Biofilm Is Less for Mucoid Isolates From Persons With Cystic Fibrosis.滤过物与伏立康唑对囊性纤维化患者黏液型分离株生物膜的协同作用较低。
Front Cell Infect Microbiol. 2022 Apr 14;12:817315. doi: 10.3389/fcimb.2022.817315. eCollection 2022.

本文引用的文献

1
Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain.西班牙临床烟曲霉分离株的唑类耐药性调查。
Clin Microbiol Infect. 2021 Aug;27(8):1170.e1-1170.e7. doi: 10.1016/j.cmi.2020.09.042. Epub 2020 Oct 1.
2
A Collaborative Tale of Diagnosing and Treating Chronic Pulmonary Aspergillosis, from the Perspectives of Clinical Microbiologists, Surgical Pathologists, and Infectious Disease Clinicians.从临床微生物学家、外科病理学家和传染病临床医生的视角看,慢性肺曲霉病诊断与治疗的协作故事
J Fungi (Basel). 2020 Jul 11;6(3):106. doi: 10.3390/jof6030106.
3
Screening for triazole resistance in clinically significant Aspergillus species; report from Pakistan.临床重要的曲霉菌属种中三唑类耐药性的筛查;来自巴基斯坦的报告。
Antimicrob Resist Infect Control. 2020 May 11;9(1):62. doi: 10.1186/s13756-020-00731-8.
4
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.侵袭性真菌病的共识定义修订与更新:来自欧洲癌症研究与治疗组织和真菌病研究组教育与研究联合会。
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. doi: 10.1093/cid/ciz1008.
5
Fatal invasive pulmonary aspergillosis caused by voriconazole-resistant Aspergillus tubingensis in a patient with solid tumor.固瘤患者中由伏立康唑耐药的管形曲霉引起的致命性侵袭性肺曲霉病。
J Infect Chemother. 2020 Mar;26(3):301-304. doi: 10.1016/j.jiac.2019.10.022. Epub 2019 Nov 29.
6
Revealing the Virulence Potential of Clinical and Environmental Isolates Using Whole-Genome Sequencing.利用全基因组测序揭示临床和环境分离株的毒力潜能
Front Microbiol. 2019 Sep 4;10:1970. doi: 10.3389/fmicb.2019.01970. eCollection 2019.
7
Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study.在一家三级医院的血液科在施工期间空气中的真菌孢子和侵袭性曲霉病:一项前瞻性队列研究。
Antimicrob Resist Infect Control. 2019 May 29;8:88. doi: 10.1186/s13756-019-0543-1. eCollection 2019.
8
The role of occupational Aspergillus exposure in the development of diseases.职业性接触曲霉菌在疾病发展中的作用。
Med Mycol. 2019 Apr 1;57(Supplement_2):S196-S205. doi: 10.1093/mmy/myy090.
9
In Vivo Selection of a Unique Tandem Repeat Mediated Azole Resistance Mechanism (TR) in Aspergillus fumigatus cyp51A, Denmark.丹麦烟曲霉中唑类药物耐药的独特串联重复介导的机制(TR)的体内选择。
Emerg Infect Dis. 2019 Mar;25(3):577-580. doi: 10.3201/eid2503.180297.
10
Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.从葡萄牙环境空气中采集的曲霉属物种-对依曲康唑耐药的烟曲霉狭义种的分子鉴定、抗真菌药敏性和 cyp51A 基因测序。
J Appl Microbiol. 2019 Apr;126(4):1140-1148. doi: 10.1111/jam.14217. Epub 2019 Feb 27.

流行病学趋势——来自国家参考实验室监测项目的视角

Trends on Epidemiology-Perspectives from a National Reference Laboratory Surveillance Program.

作者信息

Sabino Raquel, Gonçalves Paulo, Martins Melo Aryse, Simões Daniela, Oliveira Mariana, Francisco Mariana, Viegas Carla, Carvalho Dinah, Martins Carlos, Ferreira Teresa, Toscano Cristina, Simões Helena, Veríssimo Cristina

机构信息

Infectious Diseases Department, National Health Institute Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.

European Programme for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control, 16973 Solna, Sweden.

出版信息

J Fungi (Basel). 2021 Jan 6;7(1):28. doi: 10.3390/jof7010028.

DOI:10.3390/jof7010028
PMID:33418997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7825284/
Abstract

Identification of to species level is important since sibling species may display variable susceptibilities to multiple antifungal drugs and also because correct identification contributes to improve the knowledge of epidemiological studies. Two retrospective laboratory studies were conducted on surveillance at the Portuguese National Mycology Reference Laboratory. The first, covering the period 2017-2018, aimed to study the molecular epidemiology of 256 isolates obtained from patients with respiratory, subcutaneous, or systemic infections and from environmental samples. The second, using our entire collection of clinical and environmental isolates ( = 337), collected between 2012 and 2019, aimed to determine the frequency of azole-resistant isolates. sensu stricto was the most frequent species in both clinical and environmental samples. Overall, and considering all sections identified, a high frequency of cryptic species was detected, based on beta-tubulin or calmodulin sequencing (37% in clinical and 51% in environmental isolates). Regarding all isolates recovered from 2012-2019, the frequency of cryptic species was 5.3% (18/337), with the identification of (complex), , , , and . To determine the frequency of azole resistance of , isolates were screened for azole resistance using azole-agars, and 53 possible resistant isolates were tested by the CLSI microdilution reference method. Nine sensu stricto and six cryptic isolates showed high minimal inhibitory concentrations to itraconazole, voriconazole, and/or posaconazole. Real-time PCR to detect mutations and sequencing of 51A gene and its promoter were performed. The overall frequency of resistance to azoles in sensu stricto was 3.0%. With this retrospective analysis, we were able to detect one azole-resistant G54R mutant environmental isolate, collected in 2015. The TR/L98H mutation, linked to environmental transmission route of azole resistance, was the most frequently detected mutation ( = 4; 1.4%). Our findings underline the demand for correct identification and susceptibility testing of isolates.

摘要

鉴定到种水平很重要,因为近缘种可能对多种抗真菌药物表现出不同的敏感性,而且正确鉴定有助于提高流行病学研究的认知。在葡萄牙国家真菌学参考实验室进行了两项关于监测的回顾性实验室研究。第一项研究涵盖2017 - 2018年期间,旨在研究从呼吸道、皮下或全身感染患者以及环境样本中分离出的256株曲霉菌株的分子流行病学。第二项研究使用我们在2012年至2019年期间收集的全部临床和环境曲霉菌株(n = 337),旨在确定对唑类耐药的曲霉菌株的频率。狭义烟曲霉是临床和环境样本中最常见的物种。总体而言,考虑到所有鉴定出的烟曲霉部分,基于β - 微管蛋白或钙调蛋白测序检测到高频率的隐种(临床样本中为37%,环境分离株中为51%)。关于2012 - 2019年回收的所有烟曲霉分离株,隐种的频率为5.3%(18/337),鉴定出了烟曲霉复合群、烟曲霉、土曲霉、黄曲霉、构巢曲霉和黑曲霉。为了确定烟曲霉对唑类耐药的频率,使用唑类琼脂对烟曲霉分离株进行唑类耐药筛选,并通过CLSI微量稀释参考方法对53株可能耐药的分离株进行检测。9株狭义烟曲霉和6株烟曲霉隐种分离株对伊曲康唑、伏立康唑和/或泊沙康唑表现出高最低抑菌浓度。进行了实时PCR检测烟曲霉突变以及51A基因及其启动子的测序。狭义烟曲霉对唑类耐药的总体频率为3.0%。通过这项回顾性分析,我们能够检测到一株2015年收集的对唑类耐药的G54R突变环境分离株。与唑类耐药的环境传播途径相关的TR/L98H突变是最常检测到的突变(n = 4;1.4%)。我们的研究结果强调了对烟曲霉分离株进行正确鉴定和药敏试验的必要性。